Cognitive Enhancement Therapy for Alzheimer’s Disease

@article{Parnetti2012CognitiveET,
  title={Cognitive Enhancement Therapy for Alzheimer’s Disease},
  author={L. Parnetti and U. Senin and P. Mecocci},
  journal={Drugs},
  year={2012},
  volume={53},
  pages={752-768}
}
  • L. Parnetti, U. Senin, P. Mecocci
  • Published 2012
  • Medicine
  • Drugs
    • SummaryAlthough at present there is no definitive treatment or cure for Alzheimer’s disease, different pharmacological strategies are being actively investigated. At present, cholinergic therapy and nootropics and some neuronotrophic agents represent the available approaches to symptomatic treatment of Alzheimer’s disease. The use of cholinesterase inhibitors (ChEI) constitutes the best cholinergic approach to increase acetylcholine levels. Available data suggest that about 15 to 40% of… CONTINUE READING
    View on Springer
    15 Citations
    Highly Influencial Citations
    1
    Background Citations
    3
    Methods Citations
    1
    15 Citations
    Citation Type

    Citation Type

    Cognitive decline and dementia in the elderly hypertensive
    General and domain-specific neurocognitive impairments in deficit and non-deficit schizophrenia
    • 25
    Design, synthesis and evaluation of indole derivatives as multifunctional agents against Alzheimer's disease.
    • 11
    • PDF
    Cognitive Enhancement Therapy for Adults with Autism Spectrum Disorder: Results of an 18-month Feasibility Study
    • 61
    • PDF
    Neuroprotective and Antiamnesic Effects of Mitragyna inermis Willd (Rubiaceae) on Scopolamine-Induced Memory Impairment in Mice
    • 18
    • PDF
    Action-Based Cognitive Remediation for Individuals With Serious Mental Illnesses: Effects of Real-World Simulations and Goal Setting on Functional and Vocational Outcomes
    • 35
    Non-fatal endpoints alone and combined with fatal endpoints Nature of endpoint Non-fatal endpoints Stroke Retinal exudates Cardiac endpoints Heart failure Myocardial infarction Renal failure Fatal and non-fatal endpoints Stroke
    Synthesis and pharmacological evaluation of some new naphthol derived aryloxy derivatives as cognition enhancers
    • 5
    Towards the rational design of novel drugs based on solubility, partitioning/distribution, biomimetic permeability and biological activity exemplified by 1,2,4-thiadiazole derivatives.
    • 17
    • PDF
    Antiamnesic Activity of Extracts and Fraction of Desmodium Gangeticum
    • 4
    • PDF

    References

    SHOWING 1-10 OF 139 REFERENCES
    Brain selective inhibition of acetylcholinesterase: a novel approach to therapy for Alzheimer's disease.
    • 298
    Treatment of Alzheimer's disease: future directions
    • 12
    Alzheimer's disease and related disorders.
    • 99
    Mechanisms of cholinesterase inhibition in senile dementia of the alzheimer type: Clinical, pharmacological, and therapeutic aspects
    • 197
    A double-blind, placebo-controlled multicenter study of tacrine for Alzheimer's disease. The Tacrine Collaborative Study Group.
    • 523
    Alzheimer disease : therapeutic strategies
    • 73
    Idebenone in senile dementia of Alzheimer type: a multicentre study.
    • 57
    Treatment of Alzheimer's disease with cholinergic drugs.
    • V. Kumar, M. Calache
    • Medicine
    • International journal of clinical pharmacology, therapy, and toxicology
    • 1991
    • 43
    Inflammatory mechanisms in Alzheimer's disease: implications for therapy.
    • 298
    Alzheimer's disease : basic mechanisms, diagnosis and therapeutic strategies
    • 150